ACCD - Accolade Sales Growth YoY (Last 12 Months)

Brandmark of accolade.com (ACCD)

Accolade management is effectively optimizing expenses, steadily reducing the capital deficit. Despite risks of raw material supply chain disruptions and regulatory complexities in biopharmaceuticals, Accolade is developing digital medical record navigation for corporate clients. The TTM annual revenue change helps identify systemic shifts in the business, while the metric remains at 8.40, confirming the platform's resilience.

Accolade Inc (ACCD) Sales Growth YoY (TTM): for the period 02/11/2024 - 02/20/2024

Accolade (ACCD) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Accolade Health|ACCD - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Accolade, Inc.|ACCD - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Accolade|ACCD - Book Capitalization|Market Capitalization to Book Value Ratio accolade.com|ACCD - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Accolade|ACCD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Accolade Health|ACCD - Company Aggregate Debts|Debt to Book Value Ratio Accolade Health|ACCD - Company Long-Term Liabilities|Amount of Current Liabilities Accolade|Immediate Liquidity accolade.com
- earnings and market multiples details:
ACCD - Company Net Income|Expected Profit Accolade|ACCD - P/E Multiple|Projected Price to Earnings Ratio Accolade|ACCD - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Accolade, Inc.|ACCD - Operating profit EBITDA|Net earnings per one share for the last twelve months Accolade|ACCD - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months accolade.com|ACCD - Earnings growth in current year|Earnings growth forecast for next year Accolade
- sales revenue and business income indicators:
ACCD - Revenue and Sales Volume|Company Future Sales Volume Accolade Health|ACCD - P/S Multiple|Forward Price-to-Revenue Multiple Accolade Inc|ACCD - Sales Growth YoY (Last Twelve Months)
Summary company analytics:Accolade Inc - ACCD
Mass-produced product of Accolade Health

This indicator measures revenue dynamics over the last twelve months relative to the same period last year, allowing for an assessment of the business's actual scaling speed. By analyzing the year-over-year sales trajectory (TTM), an investor can confirm the effectiveness of the implementation of Accolade (ACCD) AI questionnaires, which automate patient routing and should convert into sustainable sales growth while optimizing operating expenses.

Competitor analysis for Accolade

Revenue Change YoY (Last 12 Months) HIMS (Hims & Hers Health)|Hinge Health Inc - Sales Growth YoY (TTM)|Teladoc (TDOC) - Revenue Growth YoY (Last 12 Months)|TALK: Sales Growth YoY (TTM)|LFMD - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) AMWL|MGRX (Mangoceuticals, Inc.) - Revenue Change YoY (Last 12 Months)|Revenue Growth YoY (Last 12 Months) DRIO (DarioHealth Corporation)|Revenue Change YoY (Last 12 Months) VSEE|Sales Growth YoY (Last Twelve Months) Mobile-health Network Solutions MNDR|Revenue Dynamics YoY (Last Twelve Months) BTCY|LYT - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Ontrak, Inc.|SHLT: Sales Growth YoY (TTM)|Thorne HealthTech, Inc. - Revenue Dynamics YoY (Last Twelve Months)